Smith+Nephew ((LSE: SN, NYSE:SNN), compañía global de tecnología médica, anuncia hoy que su innovador implante de reparación de cartílago CARTIHEAL AGILI-C ya está disponible para su comercialización en Europa. El
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces that its innovative CARTIHEAL AGILI-C Cartilage Repair Implant is now commercially available in Europe. The CARTIHEAL Implant will
Smith+Nephew ((LSE: SN, NYSE:SNN) azienda di tecnologia medica, annuncia il lancio commerciale in Europa di CARTIHEAL AGILI-C, l’innovativo impianto per la riparazione della cartilagine. La tecnologia sarà presentata
The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces the
The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces the
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and has completed the first surgical cases with
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces it will highlight a suite of advanced solutions for shoulder repair and reconstruction at the International Congress for Shoulder
Smith+Nephew announces results of its cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030
Smith+Nephew announces results of its cash tender offer for up to $250 million of its
Smith+Nephew announces pricing of its cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030
Smith+Nephew announces pricing of its cash tender offer for up to $250 million of its
Smith+Nephew announces cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030
Smith+Nephew announces cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030
Marking a new approach to innovation in medical robotics, the new centre will bring advances from a leading surgical robotics research group to patients more quickly Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces a breakthrough in RF resection technology for hip with its new FLOW FLEXTEND COBLATION Wand. Designed as an extension of its
Canton, Ohio—As thousands of football fans descend on Canton for the 2026 Pro Football Hall of Fame Enshrinement Week, Smith+Nephew, the Global medical technology company, will join the celebration with a series of
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been granted De Novo classification by the U.S. Food & Drug Administration (FDA) for its TESSA Spatial Surgery System.
Smith+Nephew ((LSE: SN, NYSE:SNN), the global medical technology company, today announced ASC Solutions: an expanded enterprise strategy for ambulatory surgery centers (ASCs) that takes a customer-centric approach to
